256 related articles for article (PubMed ID: 33268466)
1. Retromer retrieves the Wilson disease protein ATP7B from endolysosomes in a copper-dependent manner.
Das S; Maji S; Ruturaj ; Bhattacharya I; Saha T; Naskar N; Gupta A
J Cell Sci; 2020 Dec; 133(24):. PubMed ID: 33268466
[TBL] [Abstract][Full Text] [Related]
2. Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B).
Cater MA; La Fontaine S; Mercer JF
Biochem J; 2007 Jan; 401(1):143-53. PubMed ID: 16939419
[TBL] [Abstract][Full Text] [Related]
3. Copper directs ATP7B to the apical domain of hepatic cells via basolateral endosomes.
Nyasae LK; Schell MJ; Hubbard AL
Traffic; 2014 Dec; 15(12):1344-65. PubMed ID: 25243755
[TBL] [Abstract][Full Text] [Related]
4. Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-Golgi network.
Hasan NM; Gupta A; Polishchuk E; Yu CH; Polishchuk R; Dmitriev OY; Lutsenko S
J Biol Chem; 2012 Oct; 287(43):36041-50. PubMed ID: 22898812
[TBL] [Abstract][Full Text] [Related]
5. Critical roles for the COOH terminus of the Cu-ATPase ATP7B in protein stability, trans-Golgi network retention, copper sensing, and retrograde trafficking.
Braiterman L; Nyasae L; Leves F; Hubbard AL
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G69-81. PubMed ID: 21454443
[TBL] [Abstract][Full Text] [Related]
6. Copper-induced translocation of the Wilson disease protein ATP7B independent of Murr1/COMMD1 and Rab7.
Weiss KH; Lozoya JC; Tuma S; Gotthardt D; Reichert J; Ehehalt R; Stremmel W; Füllekrug J
Am J Pathol; 2008 Dec; 173(6):1783-94. PubMed ID: 18974300
[TBL] [Abstract][Full Text] [Related]
7. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.
Braiterman LT; Murthy A; Jayakanthan S; Nyasae L; Tzeng E; Gromadzka G; Woolf TB; Lutsenko S; Hubbard AL
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):E1364-73. PubMed ID: 24706876
[TBL] [Abstract][Full Text] [Related]
8. Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level.
Bartee MY; Lutsenko S
Biometals; 2007 Jun; 20(3-4):627-37. PubMed ID: 17268820
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
van den Berghe PV; Stapelbroek JM; Krieger E; de Bie P; van de Graaf SF; de Groot RE; van Beurden E; Spijker E; Houwen RH; Berger R; Klomp LW
Hepatology; 2009 Dec; 50(6):1783-95. PubMed ID: 19937698
[TBL] [Abstract][Full Text] [Related]
10. Clusterin and COMMD1 independently regulate degradation of the mammalian copper ATPases ATP7A and ATP7B.
Materia S; Cater MA; Klomp LW; Mercer JF; La Fontaine S
J Biol Chem; 2012 Jan; 287(4):2485-99. PubMed ID: 22130675
[TBL] [Abstract][Full Text] [Related]
11. Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.
Chesi G; Hegde RN; Iacobacci S; Concilli M; Parashuraman S; Festa BP; Polishchuk EV; Di Tullio G; Carissimo A; Montefusco S; Canetti D; Monti M; Amoresano A; Pucci P; van de Sluis B; Lutsenko S; Luini A; Polishchuk RS
Hepatology; 2016 Jun; 63(6):1842-59. PubMed ID: 26660341
[TBL] [Abstract][Full Text] [Related]
12. [Structure and function of ATP7A and ATP7B proteins--Cu-transporting ATPases].
Lenartowicz M; Krzeptowski W
Postepy Biochem; 2010; 56(3):317-27. PubMed ID: 21117320
[TBL] [Abstract][Full Text] [Related]
13. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
[TBL] [Abstract][Full Text] [Related]
14. Apical targeting and Golgi retention signals reside within a 9-amino acid sequence in the copper-ATPase, ATP7B.
Braiterman L; Nyasae L; Guo Y; Bustos R; Lutsenko S; Hubbard A
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G433-44. PubMed ID: 19033537
[TBL] [Abstract][Full Text] [Related]
15. Clusterin (apolipoprotein J), a molecular chaperone that facilitates degradation of the copper-ATPases ATP7A and ATP7B.
Materia S; Cater MA; Klomp LW; Mercer JF; La Fontaine S
J Biol Chem; 2011 Mar; 286(12):10073-83. PubMed ID: 21242307
[TBL] [Abstract][Full Text] [Related]
16. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.
Hsi G; Cullen LM; Macintyre G; Chen MM; Glerum DM; Cox DW
Hum Mutat; 2008 Apr; 29(4):491-501. PubMed ID: 18203200
[TBL] [Abstract][Full Text] [Related]
17. Diverse functional properties of Wilson disease ATP7B variants.
Huster D; Kühne A; Bhattacharjee A; Raines L; Jantsch V; Noe J; Schirrmeister W; Sommerer I; Sabri O; Berr F; Mössner J; Stieger B; Caca K; Lutsenko S
Gastroenterology; 2012 Apr; 142(4):947-956.e5. PubMed ID: 22240481
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific trafficking suggests a new role for renal ATP7B in the intracellular copper storage.
Barnes N; Bartee MY; Braiterman L; Gupta A; Ustiyan V; Zuzel V; Kaplan JH; Hubbard AL; Lutsenko S
Traffic; 2009 Jun; 10(6):767-79. PubMed ID: 19416479
[TBL] [Abstract][Full Text] [Related]
19. Cellular copper levels determine the phenotype of the Arg875 variant of ATP7B/Wilson disease protein.
Gupta A; Bhattacharjee A; Dmitriev OY; Nokhrin S; Braiterman L; Hubbard AL; Lutsenko S
Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5390-5. PubMed ID: 21406592
[TBL] [Abstract][Full Text] [Related]
20. Copper-dependent trafficking of Wilson disease mutant ATP7B proteins.
Forbes JR; Cox DW
Hum Mol Genet; 2000 Aug; 9(13):1927-35. PubMed ID: 10942420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
